| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 07/09/2009 | WO2008039087A8 Indoline derivatives and uses thereof |
| 07/09/2009 | US20090176993 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism |
| 07/09/2009 | US20090176992 Process for the preparation of highly optical pure carvedilol |
| 07/09/2009 | US20090176941 Functionalized Polymers Using Protected Thiols |
| 07/09/2009 | US20090176856 Muscarinic receptor antagonists |
| 07/09/2009 | US20090176851 Use of Spiro [Imidazolidine-4, 3' -Indole] 2, 2', 5' (1H) Triones for Treatment of Conditions Associated with Vanilloid Receptor 1 |
| 07/09/2009 | US20090176840 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 07/09/2009 | US20090176804 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 07/09/2009 | US20090176764 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 07/09/2009 | US20090176111 multifunctional intercalant for the dispersion of the layered materials in a polymeric phase through an environmentally acceptable water or solvent-borne medium to form nanocomposites with desirable properties |
| 07/09/2009 | US20090174321 Anthracene derivative, and light-emitting material, light-emitting element, light-emitting device, and electronic device using the same |
| 07/09/2009 | US20090173380 Benzoindole-based compound and dye-sensitized solar cell using the same |
| 07/09/2009 | CA2707339A1 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 07/08/2009 | EP2076493A1 Production process for bicyclic tetrahydropyrrole compounds |
| 07/08/2009 | CN100509811C Azaindoles |
| 07/08/2009 | CN100509784C Inhibitors of hepatitis C virus ns3/ns4a serine protease |
| 07/08/2009 | CN100509783C Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 07/08/2009 | CN100509761C Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules |
| 07/07/2009 | US7557140 e.g. 3-[3-(2,4-Difluoro-phenylsulfamoyl)-phenyl]-N-hydroxy-acrylamide; histone deacetylase inhibitor; anticarcinogenic, antiinflammatory agent, autoimmune diseases; leukemia, atheriosclerosis, Alzheimer's disease, rheumatoid arthritis, psoriasis |
| 07/07/2009 | US7557135 Inhibitors of cytosolic phospholipase A2 |
| 07/07/2009 | US7557130 Bicyclic heteroaromatic alanines |
| 07/07/2009 | US7557125 Fab I inhibitors |
| 07/07/2009 | US7557108 e.g. (1-cyclopentylmethyl-1H-indol-5-yl)-(4-isopropyl-piperazin-1-yl)-methanone; antagonists and/or inverse agonists at the histamine 3 receptor; antidepressant, anxiolytic agent; obesity, cardiovascular disorders |
| 07/07/2009 | US7557098 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 07/07/2009 | US7556797 Absorption, fluorescence of light; diagnosis of kidney, heart diseases |
| 07/07/2009 | CA2490002C Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 07/07/2009 | CA2450033C Viral polymerase inhibitors |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/02/2009 | WO2009082347A1 Bis- (sulf onylamino) derivatives for use in therapy |
| 07/02/2009 | WO2009081857A1 Organic electroluminescent device |
| 07/02/2009 | WO2009081800A1 Anthracene derivative, and light-emitting material, light-emitting element, light-emitting device, and electronic device using the same |
| 07/02/2009 | WO2009080799A2 Carbazole-based hole transport and /or electron blocking materials and /or host polymer materials |
| 07/02/2009 | US20090170916 4,5-substituted pyrazole-3-carboxylic acids/esters/salts; D-amino acid oxidase (DAAO) inhibitors; increase D-Serine level; reduce level of toxic products of D-Serine oxidation; activate N-methyl-D-aspartate NMDA-glutamate receptors; neuropathic agent, schizophrenia, Alzheimer's, anaxia |
| 07/02/2009 | US20090170882 Methods and compositions |
| 07/02/2009 | US20090170835 Isoindoline derivatives |
| 07/02/2009 | US20090170074 System and method for nucleic acid sequencing by polymerase synthesis |
| 07/02/2009 | US20090169483 Fluorescent photoprobe for the imaging of endothelin receptors |
| 07/02/2009 | US20090167161 Aromatic amine derivatives and organic electroluminescence device using the same |
| 07/02/2009 | CA2709510A1 Bis-(sulfonylamino) derivatives for use in therapy |
| 07/02/2009 | CA2704268A1 Receptor targeting ligands |
| 07/01/2009 | EP2074995A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 07/01/2009 | EP2074093A2 Matrix metalloproteinase inhibitors |
| 07/01/2009 | EP2074092A2 Inhibitors of d-amino acid oxidase |
| 07/01/2009 | EP2074091A1 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| 07/01/2009 | EP2074090A1 Vinylogous acids derivatives as chymase inhibitors |
| 07/01/2009 | EP2074089A2 Organic compounds |
| 07/01/2009 | EP2074088A2 N-substituted-azacyclylamines as histamine-3 antagonists |
| 07/01/2009 | EP2073807A1 Pharmaceutical combinations |
| 07/01/2009 | EP1776339B1 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
| 07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
| 07/01/2009 | EP1523474B1 Crystalline forms of imidoalkanpercarboxylic acids |
| 07/01/2009 | EP1406858B1 Substituted 4-aminocyclohexanols |
| 07/01/2009 | CN101472890A 3- (1H-indol- 3-ydindan-1-ylamine derivatives for the treatment of depression and anxiety |
| 07/01/2009 | CN101469000A Vinyl monomer, polymer derived from such monomer, and a light-emitting device using such polymer |
| 07/01/2009 | CN101468964A Processes for producing indole compound |
| 07/01/2009 | CN100506806C [1.2]-oxazin-3,5-diones |
| 07/01/2009 | CN100506795C Indene ketone diindyl class compound, preparation method and medical use thereof |
| 07/01/2009 | CN100506794C New method for preparing medicine mitiglinide for treating diabetes |
| 07/01/2009 | CN100506776C NK1 antagonists |
| 06/30/2009 | US7553974 Dipotassium salt of (2R,4R)-monatin; superior in sweetness, preservation stability, solubility, and color stability superior to those of the monopotassium salt crystal |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553872 Compounds and compositions for delivering active agents |
| 06/30/2009 | US7553865 Compounded with glyceryl monostearate, sorbitan monostearate, or stearyl alcohol; excellent use feeling and excellent absorbability, causes no phase separation into an oil layer and an aqueous layer, stability |
| 06/30/2009 | US7553848 Vanilloid receptor ligands and their use in treatments |
| 06/30/2009 | US7553604 Lower thermal decomposition temperatures; high speed laser recording; light absorbers in optical filter light absorbers |
| 06/25/2009 | WO2009078981A2 Ppar-delta ligands and methods of their use |
| 06/25/2009 | WO2009077728A1 Indoles and their therapeutic use |
| 06/25/2009 | WO2008131149A3 Crystal forms of saxagliptin and processes for preparing same |
| 06/25/2009 | US20090163721 Crystalline solids of carvedilol and processes for their preparation |
| 06/25/2009 | US20090163518 Novel Compounds |
| 06/25/2009 | US20090163494 Protein kinase inhibitors |
| 06/25/2009 | US20090163493 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor |
| 06/25/2009 | US20090162432 Stable laquinimod preparations |
| 06/25/2009 | US20090162420 Matrix-Controlled Transdermal System Comprising Salts of ACE Inhibitor Dicarboxylic Acids |
| 06/25/2009 | US20090160323 Carbazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Carbazole Derivative |
| 06/25/2009 | CA2708391A1 Ppar-delta ligands and methods of their use |
| 06/25/2009 | CA2707785A1 Indoles and their therapeutic use |
| 06/24/2009 | EP2072500A1 Oxime ester compound and photopolymerization initiator containing the compound |
| 06/24/2009 | EP1558567B1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 06/24/2009 | CN101466675A Salts and crystalline salt forms of an 2-indolinone derivative |
| 06/24/2009 | CN101466674A Process for making N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide and starting materials therefor |
| 06/24/2009 | CN101466673A Process for making salts of n-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide |
| 06/24/2009 | CN101466672A Salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide |
| 06/24/2009 | CN101463003A Substituted tricyclodecane compound as anti-cancer compound |
| 06/24/2009 | CN101463002A Dihydroxy-2-azabicyclo [2.2.1] heptane-3-carboxyl acid derivative and preparation |
| 06/24/2009 | CN101463001A Octahydro cyclopenteno [c] pyrroletetrazole derivative and preparation thereof |
| 06/24/2009 | CN101463000A 5-amino-2-azabicyclo [2.2.1] heptane-3-carboxyl acid derivatives, and preparation thereof |
| 06/24/2009 | CN101462999A Fluoro or difluoro-2-azabicyclo [2.2.1] heptane-3-carboxyl acid derivatives, and preparation thereof |
| 06/24/2009 | CN101461804A (+)-1-(3,4-dichlorrophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 06/24/2009 | CN100505966C Arylamine compound and organic electroluminescent device |
| 06/24/2009 | CN100503569C Method for preparing 4,4'- bi (4 - carboxyl phthalimide group) 3,3'- dimethyl diphenylmothane |
| 06/24/2009 | CN100503568C Process for the preparation of perindopril, its analgous compounds and salts therof using 2,5 dioxo-oxazolidine intermediate compounds |
| 06/24/2009 | CN100503567C Method for preparing-4-bromine-7-methyl isatin |
| 06/24/2009 | CN100503566C Inhibitors of cytosolic phospholipase A2 |
| 06/23/2009 | US7550624 For treating or inhibiting increased urinary urgency or urinary incontinence and/or pain |
| 06/23/2009 | US7550500 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 06/23/2009 | US7550499 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550485 Conditions ameliorated by monoamine reuptake such as hot flashes, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders; e.g. 1-[2-(1,4'-bipiperidin-1'-yl)-1-(3-chlorophenyl)ethyl]cyclohexanol dihydrochloride |
| 06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |